C1QL2: A Drug Target / Disease Biomarker (G165257)

Target Name: C1QL2

NCBI ID: G165257

C1QL2: A Drug Target / Disease Biomarker

C1QL2 is a protein that is expressed in various tissues throughout the body. It is a member of the C1Q family of proteins, which are known for their role in cell signaling and inflammation. C1QL2 has been identified as a potential drug target or biomarker, and research is being conducted to investigate its potential utility as a therapeutic agent.

C1QL2 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and blood vessels. It is a member of the C1Q family of proteins, which are known for their role in cell signaling and inflammation. The C1Q family includes a number of different proteins, including C1Q1, C1Q2, C1Q3, and C1Q4. These proteins are characterized by the presence of a unique N-terminal domain that is composed of a combination of amino acids.

One of the defining features of C1QL2 is its role in cell signaling. C1QL2 is a member of the T-cell receptor (TCR) signaling pathway, which is a critical pathway that is involved in the regulation of immune responses. C1QL2 is thought to play a role in the regulation of T-cell proliferation and differentiation, as well as in the regulation of immune cell function.

C1QL2 is also involved in the regulation of inflammation. In response to the release of pro-inflammatory cytokines, C1QL2 is thought to play a role in the regulation of the NF-kappa-B signaling pathway, which is a critical pathway that is involved in the regulation of inflammation. C1QL2 is also thought to play a role in the regulation of the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾.

C1QL2 is also involved in the regulation of cell adhesion. C1QL2 is a member of the cadherin family of proteins, which are known for their role in cell adhesion. C1QL2 is thought to play a role in the regulation of cadherin-based adhesion, as well as in the regulation of tight junction formation.

In addition to its role in cell signaling and inflammation, C1QL2 is also thought to have a number of potential therapeutic applications. For example, C1QL2 has been shown to be a potential drug target, with research being conducted to investigate its potential utility as a therapeutic agent for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the challenges in the study of C1QL2 is its relatively high complexity. C1QL2 is a member of the C1Q family of proteins, which are known for their complex structure and function. As a result, the study of C1QL2 is likely to require a combination of techniques, including biochemical, cellular, and mass spectrometry-based approaches, to fully understand its role in cell signaling and inflammation.

In conclusion, C1QL2 is a protein that is expressed in various tissues throughout the body and is involved in a number of critical processes in cell signaling and inflammation. As a result, C1QL2 is a potential drug target or biomarker with a number of potential therapeutic applications. Further research is needed to fully understand its role in cell signaling and inflammation and to develop effective therapies based on its properties.

Protein Name: Complement C1q Like 2

Functions: May regulate the number of excitatory synapses that are formed on hippocampus neurons. Has no effect on inhibitory synapses (By similarity)

More Common Targets